FDA Clears True Definition Deep Learning Software for High-Resolution CT Imaging

The Food and Drug Administration (FDA) has granted 510(k) clearance for True Definition DL, a deep learning software that offers a variety of features to bolster high-resolution imaging for computed tomography (CT) scans.

GE HealthCare, the developer of True Definition DL, said the software offers deep neural network capabilities for improving spatial resolution and enhancing artifact suppression along with faster image processing.

In addition to a 1024 matrix for high resolution display, GE HealthCare noted the True Definition DL software emphasizes image sharpness and detailed views of fine anatomical structures in pulmonary, musculoskeletal and inner ear imaging.

“True Definition DL delivers exceptional spatial resolution for visualizing very small anatomical structures,” shares Stefanie Bitschnau, MD, a radiologist affiliated with Radiomed in Wiesbaden, Germany. “In chest imaging, this level of detail is particularly valuable for assessing small airways, supporting earlier and more confident evaluation of interstitial lung disease. Additionally, the technology is highly beneficial in applications such as inner ear imaging with petrous bone scans, where it allows us to clearly visualize the auditory ossicles and detect erosions at an early stage. This improved definition also supports more confident fracture assessment.”